Literature DB >> 8375065

Sandwich enzyme immunoassay of cystatin C in serum with commercially available antibodies.

M Pergande1, K Jung.   

Abstract

We developed a sandwich enzyme immunoassay for determining cystatin C in serum by using commercially available antibodies. We optimized each assay step (e.g., concentrations of coating rabbit anti-human cystatin C antibodies and horseradish peroxidase-conjugated antibodies) and studied the binding kinetics of antigen and antibodies. The within-assay CV was < 5%, the between-assay CV was 8.8%, the detection limit was 0.9 microgram/L, and the assay can be performed within 2 h. Cystatin C concentrations in sera from men were significantly higher than in women (mean and SD: 2.14 +/- 0.31 vs 1.78 +/- 0.26 mg/L). We studied the cystatin C concentrations in sera of 31 outpatients with suspected kidney damages to characterize the behavior of this low-M(r) protein as a possible indicator for estimating the glomerular filtration rate. The correlation with the values obtained by a standard isotopic method involving 99mTc-diethylenetriaminopentaacetic acid was rs = -0.89. The diagnostic sensitivity of cystatin C was 88.2% of that of the standard isotope clearance method and better than those of the conventional serum indicators of reduced kidney function, beta 2-microglobulin (64.7%) and creatinine (52.9%).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375065

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

Review 1.  Commentary: clinical diagnostic use of cystatin C.

Authors:  Davis Massey
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin.

Authors:  Fabienne Thomas; Sophie Séronie-Vivien; Laurence Gladieff; Florence Dalenc; Valérie Durrand; Laurence Malard; Thierry Lafont; Muriel Poublanc; Roland Bugat; Etienne Chatelut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Age, gender, and race effects on cystatin C levels in US adolescents.

Authors:  Darcy Groesbeck; Anna Köttgen; Rulan Parekh; Elizabeth Selvin; George J Schwartz; Josef Coresh; Susan Furth
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

4.  Cystatin C--a paradigm of evidence based laboratory medicine.

Authors:  Janice S C Chew; Mohammed Saleem; Christopher M Florkowski; Peter M George
Journal:  Clin Biochem Rev       Date:  2008-05

5.  Cystatin C-A novel marker of glomerular filtration rate: A review.

Authors:  Purnima Dey Sarkar; G Rajeshwari; T M Shivaprakash
Journal:  Indian J Clin Biochem       Date:  2005-01

6.  Clinical value of serum cystatin C by ELISA for estimation of glomerular filtration rate.

Authors:  Xunhui Xu; Jianzhou Zou; Xiaoqiang Ding; Dingguang Xin; Yushen Ren
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

7.  Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients.

Authors:  Patricia Villa; Manuel Jiménez; Maria-Cruz Soriano; Jesus Manzanares; Pilar Casasnovas
Journal:  Crit Care       Date:  2005-02-07       Impact factor: 9.097

Review 8.  Cystatin C--properties and use as diagnostic marker.

Authors:  A O Grubb
Journal:  Adv Clin Chem       Date:  2000       Impact factor: 5.394

9.  Codon preference optimization increases prokaryotic cystatin C expression.

Authors:  Qing Wang; Cui Mei; Honghua Zhen; Jess Zhu
Journal:  J Biomed Biotechnol       Date:  2012-10-03

10.  Cystatin C in Acute Coronary Syndrome.

Authors:  Moushumi Lodh; Ashok Parida; Joy Sanyal; Arunangshu Ganguly
Journal:  EJIFCC       Date:  2013-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.